PTSDPhase 3PTF4NCT01955538
The Effect of BAT Versus Mixed Physical Activity as add-on Treatment for Traumatised Refugees.
A Phase 3 study testing Basic Body Awareness Therapy and Mixed physical activity in people with PTSD and Depression, run by Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital at 1 site in Denmark.
Trial summary
The aim of this randomised controlled trial is to study two types of physical activities as add-on treatment, compared to treatment as usual for traumatised refugees. Hereby, the study will examine the evidence of an often-used treatment modality in a field where very little research yet has been conducted. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- PTSD, Depression, Pain
- What is being tested?
- Basic Body Awareness Therapy and Mixed physical activity
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 338 participants
- Where
- 1 siteDenmark
- Study dates
- Sep 2013to Sep 2015
- Phase
- Phase 3
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients referred to treatment for PTSD at Competence Centre for Transcultural Psychiatry from September 2013 to May 2015.
- Adults (18 years or older)
- Refugees or persons who have been brought in under family reunification
- Symptoms of PTSD pursuant to the International Classification of Diseases (ICD-10) research criteria.
- Psychological trauma in the anamnesis. Trauma is typically imprisonment or detention with torture (according to the United Nations definition of torture) or acts of cruel, inhuman and degrading treatment or punishment. Trauma can also be organised violence, long-term political persecution and harassment, or war and civil war experiences.
- Assessed by a doctor to be motivated for treatment
- Informed consent.
Who cannot join
- Severe psychotic disorder (defined as patients with an ICD-10 diagnosis F2x and F30.1-F30.9). Patients are excluded only if the psychotic-like experiences are assessed to be part of an independent psychotic disorder and not part of a severe PTSD and/or depression.
- Current abuser of drugs and alcohol (F1x.24-F1x.26).
- In need of admission to psychiatric hospital.
- No informed consent.
- Physical handicaps that make the person unable to participate in the physical activity.
- Cardiac arrhythmia identified on the electrocardiogram taken before start of the treatment or symptoms of heart problems that are unclarified.
Trial locations and contacts
1 site in 1 country.
Denmark1 site
Competence Centre for Transcultural Psychiatry, Psychiatric Centre Ballerup.
Copenhagen, Hellerup, 2900
About this study
Official title: Treatment of Traumatised Refugees: the Effect of Basic Body Awareness Therapy Versus Mixed Physical Activity as add-on Treatment. A Randomised Controlled Trial.
The aim of this randomised controlled trial is to study two types of physical activities as add-on treatment, compared to treatment as usual for traumatised refugees. Hereby, the study will examine the evidence of an often-used treatment modality in a field where very little research yet has been conducted.
Read the detailed description
About the clinic: The study will be carried out at the Competence Centre for Transcultural Psychiatry Denmark (CTP) (before January 2013 named Psychiatric Trauma Clinic for Refugees (PTF)). The clinic was established in 2008 and since 2009 the clinic has been carrying out randomised, controlled trials aiming to increase knowledge about the treatment effect of different types of treatment for traumatised refugees. The target group of the centre is traumatised refugees with PTSD, depression and anxiety. Patients are referred to CTP by general practitioners or psychiatrists. CTP treats approximately 200 patients/year.
The treatment is inter-disciplinary and consists of consultations with a medical doctor whereby pharmacological treatment according to best practice in the field is given, supplemented by cognitive behavioural therapy by a psychologist. Manuals are used for both the treatment given by the medical doctor as well as the psychologist. The total duration of treatment is 6 months.
Material and methods: 310 patients will be included from September 2013 to approximately May 2015. At the referral interview it is clarified whether the patient meets the inclusion or exclusion criteria. If the patient meets the inclusion criteria and gives her/his consent to participate, the patient is randomised to one of the three intervention groups:
- Control group: receives treatment as usual (TAU) consisting of: 6 months of consultations and medical treatment according to best clinical practice by a medical doctor as well as manual-based Cognitive Behaviour Therapy by a psychologist.
- Basic Body Awareness Therapy (BBAT): TAU + BBAT.
- Mixed physical activity (MPA): TAU + MPA
The duration of B and C is 20 weeks each, 1 hour/week.
The physical activity will be on individual sessions.
- Quality assurance plan: Good Clinical Practice (GCP) is monitoring and auditing the project from the project's start to its end. Moreover, The Competence Centre for Transcultural Psychiatry (CTP) has a monitoring team monitoring the data being registered as data are coming in.
- Data checks: GCP as well as the before mentioned monitoring team will be doing data checks and auditing during the time the trial is running.
- Source data verification: to assess the accuracy, completeness and representativity of registry data, the monitoring team of CTP is during the trial comparing the data registered manually by doctors, psychologists, physiotherapist and social workers with e.g. the papers filled in by the patients themselves. Data registered from the patients in the trial are also registered from the patients that are not participating in the trial. By comparing those data, this will show the representativity of the data from this population.
- Standard Operating Procedures: All adverse events will be registered in the individual patient records in the period from the first consultation at the centre to the last consultation at the centre of each patient.
All Serious Adverse Events (SAEs) will be reported by sponsor or investigator to The National Committee on Health Research Ethics (within 7 days after investigator has become aware of any such), with comments enclosed on potential consequences for the trial.
Sponsor will yearly submit a report to The National Committee on Health Research Ethics on all SAEs, with an assessment attached on the security of the patients participating in the trial.
The report will be submitted each year on the day when the trial was given approval from The National Committee on Health Research Ethics.
A list of all patients screened for participating in the trial and of all patients finally included in the trial will be kept.
- Data dictionary: not relevant.
- Randomisation is carried out by the Department of Biostatistics at the University of Copenhagen, with practical assistance from a group of secretaries not linked to the daily work at CTP. The participants will be stratified by gender and severity of PTSD symptoms on the basis of Harvard Trauma Questionnaire (HTQ). Blinding of patients and practitioners is not considered to be possible, but intervention-group blinded Hamilton Depression and Anxiety ratings will be carried out at the beginning and at the end of treatment. The Hamilton raters are medical students trained at the clinic and take part in regular joint ratings to ensure high quality and inter-rater reliability.
- Data processing/statistical analysis:
Size of material and power calculation:
If 200 patients are divided into three groups of about 65 patients, power to detect a group difference in the treatment effect of ½ standard deviation (SD) will be 81%, while power to detect a difference of 1 SD will be close to 100%. Differences in quantitative outcomes less than ½ SD between the two treatments are considered to be less relevant from a clinical point of view. Cut-offs are available for several rating scales, and these can be used to define categorical outcome variables. If for example the proportions below cut-off for clinical case status are 50% and 25% in two groups, power will be close to 80% to detect a significant group differences.
Data analysis: The primary outcome variables are differences during the treatment course calculated as differences between start, middle and end ratings. The unadjusted differences between the two intervention groups can be measured by a t-test, while adjustment of the differences for baseline values and possible background factors (such as gender and age) can be done by ANCOVA/linear regression.
In addition, cut-off can be used on symptom scores and logistic regression analyses can be carried out with over/under cut-off as binary outcome. In addition to completer analyses, drop-out analysis and intention-to-treat analyses will be carried out.
Hypotheses concerning predictors of treatment effects can be analysed by including the potential predictors in linear or logistic regression models including treatment group and relevant covariates.
- Conditions
- PTSD, Depression, Pain
- Being tested
- Control, Basic Body Awareness Therapy, Mixed physical activity
- Medical subject headings
- Stress Disorders, Post-Traumatic, Depression, Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ControlOther
Psychiatric treatment as usual for 6 months according to best clinical practice.
Basic Body Awareness TherapyOther
20 weeks, 1 hour/week.
Mixed physical activityOther
20 weeks, 1 hour/week.
| Study group | Role | What they receive |
|---|---|---|
| Control | Active comparator | Psychiatric treatment as usual for 6 months according to best clinical practice: 10 consultations with a medical doctor (medication and psycho-education) as well as 16 consultations with a psychologist. Receives: Other: Control; Other: Basic Body Awareness Therapy; Other: Mixed physical activity |
| Basic Body Awareness Therapy | Experimental | Standard psychiatric treatment + Basic Body Awareness Therapy for 20 weeks, 1 hour/week. Receives: Other: Basic Body Awareness Therapy |
| Mixed physical activity | Experimental | Standard psychiatric treatment + Mixed physical activity for 20 weeks, 1 hour/week. Receives: Other: Mixed physical activity |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Harvard Trauma Questionnaire (HTQ)
Measured: Assessing a potential change between baseline at the beginning of treatment, after three months and after 6 months (at the end of treatment).
Secondary outcomes (11)
Change in Hopkins Symptom Check List (HSCL-25)
Measured: Assessing a potential change between baseline at the beginning of treatment, after three months and after 6 months (at the end of treatment).
Change in Hamilton depression + anxiety (HAM D+A)
Measured: Assessing a potential change between baseline at the beginning of the treatment and after 6 months (at the end of treatment).
Change in World Health Organisation-5 (WHO5)
Measured: Assessing a potential change between baseline at the beginning of treatment, after three months and after 6 months (at the end of treatment).
Change in Sheehan Disability Scale
Measured: Assessing a potential change between baseline at the beginning of treatment, after three months and after 6 months (at the end of treatment).
Change in Visual Analogue Scale (VAS)
Measured: Assessing a potential change between baseline at the beginning of treatment, after three months and after 6 months (at the end of treatment).
Change in Brief Pain Inventory Short Form (BPI)
Measured: Assessing a potential change between baseline at the beginning of the treatment and after 6 months (at the end of treatment).
Change in Multidimensional Assessment of Interoceptive Awareness (MAIA)
Measured: Assessing a potential change between baseline at the beginning of the treatment and after 6 months (at the end of treatment).
Change in Dynamic Gait Index (DGI)
Measured: Assessing a potential change between baseline at the beginning of the treatment and after 6 months (at the end of treatment).
Change in Senior Fitness Test (SFT)
Measured: Assessing a potential change between baseline at the beginning of the treatment and after 6 months (at the end of treatment).
Change in De Morton Mobility Index (DEMMI)
Measured: Assessing a potential change between baseline at the beginning of the treatment and after 6 months (at the end of treatment).
Change in Global assessment of function (GAF)
Measured: Assessing a potential change between baseline at the beginning of treatment, after three months and after 6 months (at the end of treatment).
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Oct 2013 (estimated)
- Study startSep 2013
- Primary completionSep 2015
- Study completionSep 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for PTSDStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 3
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 338 participants (actual)
Sponsor and investigators
- Lead sponsor
- Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- TrygFonden, Denmark
- Responsible party
- Sponsor
- Investigators
- Maja Sticker Nordbrandt, MD, Principal investigator, Competence Centre for Transcultural Psychiatry
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01955538
- Sponsor's protocol ID
- PTF4
- Acronym
- PTF4
- Status last verified
- Apr 2016
- First submitted
- 18 Sep 2013
- Last updated
- 29 Apr 2016
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Masmas TN, Moller E, Buhmann C, Bunch V, Jensen JH, Hansen TN, Jorgensen LM, Kjaer C, Mannstaedt M, Oxholm A, Skau J, Theilade LA, Worm L, Ekstrom M. [Health status and degree of traumatisation among newly arrived asylum seeker--secondary publication]. Ugeskr Laeger. 2010 Jan 11;172(2):120-4. Danish.
PubMed 20376916Olsen DR, Montgomery E, Bojholm S, Foldspang A. Prevalence of pain in the head, back and feet in refugees previously exposed to torture: a ten-year follow-up study. Disabil Rehabil. 2007 Jan 30;29(2):163-71. doi: 10.1080/09638280600747645.
PubMed 17364766Nordbrandt MS, Sonne C, Mortensen EL, Carlsson J. Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual-A pragmatic randomised controlled trial. PLoS One. 2020 Mar 12;15(3):e0230300. doi: 10.1371/journal.pone.0230300. eCollection 2020.
PubMed 32163509Nordbrandt MS, Carlsson J, Lindberg LG, Sandahl H, Mortensen EL. Treatment of traumatised refugees with basic body awareness therapy versus mixed physical activity as add-on treatment: Study protocol of a randomised controlled trial. Trials. 2015 Oct 22;16:477. doi: 10.1186/s13063-015-0974-9.
PubMed 26492879
Study at a glance
From the registry record, last updated by the sponsor on 29 Apr 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Treatment of Traumatised Refugees: the Effect of Basic Body Awareness Therapy Versus Mixed Physical Activity as add-on Treatment. A Randomised Controlled Trial.
- ClinicalTrials.gov ID
- NCT01955538
- Acronym / sponsor ID
- PTF4 / PTF4
- Conditions
- PTSD, Depression, Pain
- Phase
- Phase 3
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 338 participants (actual)
- Lead sponsor
- Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg HospitalUniversity, hospital or other
- Collaborators
- TrygFonden, Denmark
- Study start
- Sep 2013
- Primary completion
- Sep 2015 (actual)
- Study completion
- Sep 2015 (actual)
- First posted
- 7 Oct 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this randomised controlled trial is to study two types of physical activities as add-on treatment, compared to treatment as usual for traumatised refugees. Hereby, the study will examine the evidence of an often-used treatment modality in a field where very little research yet has been conducted.
Detailed description
About the clinic: The study will be carried out at the Competence Centre for Transcultural Psychiatry Denmark (CTP) (before January 2013 named Psychiatric Trauma Clinic for Refugees (PTF)). The clinic was established in 2008 and since 2009 the clinic has been carrying out randomised, controlled trials aiming to increase knowledge about the treatment effect of different types of treatment for traumatised refugees. The target group of the centre is traumatised refugees with PTSD, depression and anxiety. Patients are referred to CTP by general practitioners or psychiatrists. CTP treats approximately 200 patients/year.
The treatment is inter-disciplinary and consists of consultations with a medical doctor whereby pharmacological treatment according to best practice in the field is given, supplemented by cognitive behavioural therapy by a psychologist. Manuals are used for both the treatment given by the medical doctor as well as the psychologist. The total duration of treatment is 6 months.
Material and methods: 310 patients will be included from September 2013 to approximately May 2015. At the referral interview it is clarified whether the patient meets the inclusion or exclusion criteria. If the patient meets the inclusion criteria and gives her/his consent to participate, the patient is randomised to one of the three intervention groups:
- Control group: receives treatment as usual (TAU) consisting of: 6 months of consultations and medical treatment according to best clinical practice by a medical doctor as well as manual-based Cognitive Behaviour Therapy by a psychologist.
- Basic Body Awareness Therapy (BBAT): TAU + BBAT.
- Mixed physical activity (MPA): TAU + MPA
The duration of B and C is 20 weeks each, 1 hour/week.
The physical activity will be on individual sessions.
- Quality assurance plan: Good Clinical Practice (GCP) is monitoring and auditing the project from the project's start to its end. Moreover, The Competence Centre for Transcultural Psychiatry (CTP) has a monitoring team monitoring the data being registered as data are coming in.
- Data checks: GCP as well as the before mentioned monitoring team will be doing data checks and auditing during the time the trial is running.
- Source data verification: to assess the accuracy, completeness and representativity of registry data, the monitoring team of CTP is during the trial comparing the data registered manually by doctors, psychologists, physiotherapist and social workers with e.g. the papers filled in by the patients themselves. Data registered from the patients in the trial are also registered from the patients that are not participating in the trial. By comparing those data, this will show the representativity of the data from this population.
- Standard Operating Procedures: All adverse events will be registered in the individual patient records in the period from the first consultation at the centre to the last consultation at the centre of each patient.
All Serious Adverse Events (SAEs) will be reported by sponsor or investigator to The National Committee on Health Research Ethics (within 7 days after investigator has become aware of any such), with comments enclosed on potential consequences for the trial.
Sponsor will yearly submit a report to The National Committee on Health Research Ethics on all SAEs, with an assessment attached on the security of the patients participating in the trial.
The report will be submitted each year on the day when the trial was given approval from The National Committee on Health Research Ethics.
A list of all patients screened for participating in the trial and of all patients finally included in the trial will be kept.
- Data dictionary: not relevant.
- Randomisation is carried out by the Department of Biostatistics at the University of Copenhagen, with practical assistance from a group of secretaries not linked to the daily work at CTP. The participants will be stratified by gender and severity of PTSD symptoms on the basis of Harvard Trauma Questionnaire (HTQ). Blinding of patients and practitioners is not considered to be possible, but intervention-group blinded Hamilton Depression and Anxiety ratings will be carried out at the beginning and at the end of treatment. The Hamilton raters are medical students trained at the clinic and take part in regular joint ratings to ensure high quality and inter-rater reliability.
- Data processing/statistical analysis:
Size of material and power calculation:
If 200 patients are divided into three groups of about 65 patients, power to detect a group difference in the treatment effect of ½ standard deviation (SD) will be 81%, while power to detect a difference of 1 SD will be close to 100%. Differences in quantitative outcomes less than ½ SD between the two treatments are considered to be less relevant from a clinical point of view. Cut-offs are available for several rating scales, and these can be used to define categorical outcome variables. If for example the proportions below cut-off for clinical case status are 50% and 25% in two groups, power will be close to 80% to detect a significant group differences.
Data analysis: The primary outcome variables are differences during the treatment course calculated as differences between start, middle and end ratings. The unadjusted differences between the two intervention groups can be measured by a t-test, while adjustment of the differences for baseline values and possible background factors (such as gender and age) can be done by ANCOVA/linear regression.
In addition, cut-off can be used on symptom scores and logistic regression analyses can be carried out with over/under cut-off as binary outcome. In addition to completer analyses, drop-out analysis and intention-to-treat analyses will be carried out.
Hypotheses concerning predictors of treatment effects can be analysed by including the potential predictors in linear or logistic regression models including treatment group and relevant covariates.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Control | Active comparator | Other: Control, Other: Basic Body Awareness Therapy, Other: Mixed physical activityPsychiatric treatment as usual for 6 months according to best clinical practice: 10 consultations with a medical doctor (medication and psycho-education) as well as 16 consultations with a psychologist. |
| Basic Body Awareness Therapy | Experimental | Other: Basic Body Awareness TherapyStandard psychiatric treatment + Basic Body Awareness Therapy for 20 weeks, 1 hour/week. |
| Mixed physical activity | Experimental | Other: Mixed physical activityStandard psychiatric treatment + Mixed physical activity for 20 weeks, 1 hour/week. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Patients referred to treatment for PTSD at Competence Centre for Transcultural Psychiatry from September 2013 to May 2015.
- Adults (18 years or older)
- Refugees or persons who have been brought in under family reunification
- Symptoms of PTSD pursuant to the International Classification of Diseases (ICD-10) research criteria.
- Psychological trauma in the anamnesis. Trauma is typically imprisonment or detention with torture (according to the United Nations definition of torture) or acts of cruel, inhuman and degrading treatment or punishment. Trauma can also be organised violence, long-term political persecution and harassment, or war and civil war experiences.
Key exclusion criteria (6 listed)
- Severe psychotic disorder (defined as patients with an ICD-10 diagnosis F2x and F30.1-F30.9). Patients are excluded only if the psychotic-like experiences are assessed to be part of an independent psychotic disorder and not part of a severe PTSD and/or depression.
- Current abuser of drugs and alcohol (F1x.24-F1x.26).
- In need of admission to psychiatric hospital.
- No informed consent.
- Physical handicaps that make the person unable to participate in the physical activity.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ControlPsychiatric treatment as usual for 6 months according to best clinical practice. | Other | Control |
| Basic Body Awareness Therapy20 weeks, 1 hour/week. | Other | Basic Body Awareness Therapy, Control |
| Mixed physical activity20 weeks, 1 hour/week. | Other | Control, Mixed physical activity |
Primary outcome
Change in Harvard Trauma Questionnaire (HTQ)
Time frame: Assessing a potential change between baseline at the beginning of treatment, after three months and after 6 months (at the end of treatment).
11 secondary outcomes
Change in Hopkins Symptom Check List (HSCL-25)
Time frame: Assessing a potential change between baseline at the beginning of treatment, after three months and after 6 months (at the end of treatment).
Change in Hamilton depression + anxiety (HAM D+A)
Time frame: Assessing a potential change between baseline at the beginning of the treatment and after 6 months (at the end of treatment).
Change in World Health Organisation-5 (WHO5)
Time frame: Assessing a potential change between baseline at the beginning of treatment, after three months and after 6 months (at the end of treatment).
Change in Sheehan Disability Scale
Time frame: Assessing a potential change between baseline at the beginning of treatment, after three months and after 6 months (at the end of treatment).
Change in Visual Analogue Scale (VAS)
Time frame: Assessing a potential change between baseline at the beginning of treatment, after three months and after 6 months (at the end of treatment).
Change in Brief Pain Inventory Short Form (BPI)
Time frame: Assessing a potential change between baseline at the beginning of the treatment and after 6 months (at the end of treatment).
Change in Multidimensional Assessment of Interoceptive Awareness (MAIA)
Time frame: Assessing a potential change between baseline at the beginning of the treatment and after 6 months (at the end of treatment).
Change in Dynamic Gait Index (DGI)
Time frame: Assessing a potential change between baseline at the beginning of the treatment and after 6 months (at the end of treatment).
Change in Senior Fitness Test (SFT)
Time frame: Assessing a potential change between baseline at the beginning of the treatment and after 6 months (at the end of treatment).
Change in De Morton Mobility Index (DEMMI)
Time frame: Assessing a potential change between baseline at the beginning of the treatment and after 6 months (at the end of treatment).
Change in Global assessment of function (GAF)
Time frame: Assessing a potential change between baseline at the beginning of treatment, after three months and after 6 months (at the end of treatment).
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Apr 2016.
- Background: PubMed 20376916Masmas TN, Moller E, Buhmann C, Bunch V, Jensen JH, Hansen TN, Jorgensen LM, Kjaer C, Mannstaedt M, Oxholm A, Skau J, Theilade LA, Worm L, Ekstrom M. [Health status and degree of traumatisation among newly arrived asylum seeker--secondary publication]. Ugeskr Laeger. 2010 Jan 11;172(2):120-4. Danish.
- Background: PubMed 17364766Olsen DR, Montgomery E, Bojholm S, Foldspang A. Prevalence of pain in the head, back and feet in refugees previously exposed to torture: a ten-year follow-up study. Disabil Rehabil. 2007 Jan 30;29(2):163-71. doi: 10.1080/09638280600747645.
- Derived from this study: PubMed 32163509Nordbrandt MS, Sonne C, Mortensen EL, Carlsson J. Trauma-affected refugees treated with basic body awareness therapy or mixed physical activity as augmentation to treatment as usual-A pragmatic randomised controlled trial. PLoS One. 2020 Mar 12;15(3):e0230300. doi: 10.1371/journal.pone.0230300. eCollection 2020.
- Derived from this study: PubMed 26492879Nordbrandt MS, Carlsson J, Lindberg LG, Sandahl H, Mortensen EL. Treatment of traumatised refugees with basic body awareness therapy versus mixed physical activity as add-on treatment: Study protocol of a randomised controlled trial. Trials. 2015 Oct 22;16:477. doi: 10.1186/s13063-015-0974-9.
Related trials for PTSD
Recruiting
NightWare and Cardiovascular Health in Women With PTSD
Post Traumatic Stress Disorder, Cardiovascular Diseases
Not yet recruiting
A Transdiagnostic Sleep Health Intervention for Veterans With PTSD
Stress Disorders, Post-Traumatic, Sleep Initiation and Maintenance Disorders
Not yet recruitingPhase 3
Women Who Are Victims of Violence: Treatment of PTSD Through Reactivation of Traumatic Memories Using Propranolol
Post-Traumatic Stress Disorder, PTSD
RecruitingPhase 4
The Effects of Orexin Antagonism on Fear Extinction in PTSD
Insomnia, PTSD
Recruiting
Advancing Skills Through Consultation, Education, and Novel Technologies
PTSD - Post Traumatic Stress Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Maja Sticker Nordbrandt, MD principal investigator
Competence Centre for Transcultural Psychiatry
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 3 study testing Basic Body Awareness Therapy and Mixed physical activity in people with PTSD and Depression, run by Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital at 1 site in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 29 Apr 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Harvard Trauma Questionnaire (HTQ) (time frame: Assessing a potential change between baseline at the beginning of treatment, after three months and after 6 months (at the end of treatment).). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01955538, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Apr 2016.